Loading...
Reach Banner
Keywords
Last name
Institution

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy.

PropertyValue
has major subject area list Cytochrome P-450 CYP2C9; Genetic Testing; Practice Guidelines as Topic; Vitamin K Epoxide Reductases; Warfarin
information resource reference Shaw K, Amstutz U, Kim RB, Lesko LJ, Turgeon J, Michaud V, Hwang S, Ito S, Ross C, Carleton BC. Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy. Ther Drug Monit. 2015 Aug; 37(4):428-36.
label Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy.

Search criteria
  • Genetic Testing